v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 9,009,184 $ 35,074,880
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and other amortization 302,168 274,294
Stock-based compensation 1,962,379 2,136,719
Write down/(recovery) of inventory, net (623,889) 471,971
Deferred income taxes, net 1,638,853 6,887,501
Deferred IV TPOXX® revenue (10,240,000) (90,800)
Changes in assets and liabilities:    
Accounts receivable (3,906,493) 14,679,752
Inventory 7,905,114 13,474,873
Prepaid expenses and other assets 1,112,383 306,137
Accounts payable, accrued expenses and other liabilities (270,194) 773,484
Income tax payable (379,665) (3,842,106)
Net cash provided by operating activities 6,509,840 70,146,705
Cash flows from investing activities:    
Capital expenditures 0 (24,894)
Cash used in investing activities 0 (24,894)
Cash flows from financing activities:    
Payment of employee tax obligations for common stock tendered (585,161) (192,306)
Payment of dividend (43,306,649) (42,866,683)
Cash used in financing activities (43,891,810) (43,058,989)
Net (decrease)/increase in cash and cash equivalents (37,381,970) 27,062,822
Cash and cash equivalents at the beginning of period 154,966,414 155,400,262
Cash and cash equivalents at end of period 117,584,444 182,463,084
Supplemental disclosure of non-cash investing activities:    
Purchase of manufacturing equipment $ 743,062 $ 0